
Figure 4. Comparison of ADCC activity of NK-92 mCD16 and NK-92 hCD16 cell lines toward human EBV-LCL preincubating with increasing concentrations of murine IgG, IgG2a and IgG2b anti-CD20. All Data are presented as the mean of 2 or 3 independent experiments ± SD of the percent of specific lysis at effector-to-target ratio = 10:1.